These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23796359)

  • 21. Intestinal permeability and effects of Lactobacillus rhamnosus therapy in children with short bowel syndrome.
    Sentongo TA; Cohran V; Korff S; Sullivan C; Iyer K; Zheng X
    J Pediatr Gastroenterol Nutr; 2008 Jan; 46(1):41-7. PubMed ID: 18162832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of a multi-strain probiotic on the resistance toward Escherichia coli challenge in a randomized, placebo-controlled, double-blind intervention study.
    Ten Bruggencate SJ; Girard SA; Floris-Vollenbroek EG; Bhardwaj R; Tompkins TA
    Eur J Clin Nutr; 2015 Mar; 69(3):385-91. PubMed ID: 25369827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between chronic use of proton pump inhibitors and small- intestinal bacterial overgrowth assessed using lactulose hydrogen breath tests.
    Fujiwara Y; Watanabe T; Muraki M; Yamagami H; Tanigawa T; Shiba M; Tominaga K; Arakawa T
    Hepatogastroenterology; 2015; 62(138):268-72. PubMed ID: 25916046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of wu chu yu tang on gastroesophageal reflux disease: Randomized, double-blind, placebo-controlled trial.
    Shih YS; Tsai CH; Li TC; Yu CJ; Chou JW; Feng CL; Wang KT; Lai HC; Hsieh CL
    Phytomedicine; 2019 Mar; 56():118-125. PubMed ID: 30668332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy.
    Lombardo L; Foti M; Ruggia O; Chiecchio A
    Clin Gastroenterol Hepatol; 2010 Jun; 8(6):504-8. PubMed ID: 20060064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial.
    Attar A; Flourié B; Rambaud JC; Franchisseur C; Ruszniewski P; Bouhnik Y
    Gastroenterology; 1999 Oct; 117(4):794-7. PubMed ID: 10500060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
    Goldenberg JZ; Lytvyn L; Steurich J; Parkin P; Mahant S; Johnston BC
    Cochrane Database Syst Rev; 2015 Dec; (12):CD004827. PubMed ID: 26695080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is small-bowel bacterial overgrowth an underdiagnosed disorder in children with gastrointestinal symptoms?
    Jones HF; Davidson GP; Brooks DA; Butler RN
    J Pediatr Gastroenterol Nutr; 2011 May; 52(5):632-4. PubMed ID: 21464754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double blind randomized trial showing probiotics to be ineffective in acute diarrhea in Indonesian children.
    Hegar B; Waspada IM; Gunardi H; Vandenplas Y
    Indian J Pediatr; 2015 May; 82(5):410-4. PubMed ID: 24777621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small bowel bacterial overgrowth in adults: a potential contributor to intestinal failure.
    Ziegler TR; Cole CR
    Curr Gastroenterol Rep; 2007 Dec; 9(6):463-7. PubMed ID: 18377796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial.
    Ghoshal UC; Srivastava D; Misra A; Ghoshal U
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):281-9. PubMed ID: 26731696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Probiotic Use on Gastrointestinal Symptoms in the Late Postoperative Period of Bariatric Surgery: A Cross-Over, Randomized, Triple-Blind, Placebo-Controlled Study.
    Wagner NRF; Lopes MCP; Fernandes R; Taconelli CA; Nascimento GM; Pessini J; Trindade EBSM; Campos ACL
    Obes Surg; 2024 Apr; 34(4):1306-1315. PubMed ID: 38418752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lactobacillus paracasei F19 versus placebo for the prevention of proton pump inhibitor-induced bowel symptoms: a randomized clinical trial.
    Compare D; Rocco A; Sgamato C; Coccoli P; Campo SM; Nazionale I; Larussa T; Luzza F; Chiodini P; Nardone G
    Dig Liver Dis; 2015 Apr; 47(4):273-9. PubMed ID: 25660822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The protective effect of
    Yoshihara T; Oikawa Y; Kato T; Kessoku T; Kobayashi T; Kato S; Misawa N; Ashikari K; Fuyuki A; Ohkubo H; Higurashi T; Tateishi Y; Tanaka Y; Nakajima S; Ohno H; Wada K; Nakajima A
    Gut Microbes; 2020 Sep; 11(5):1385-1404. PubMed ID: 32515658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial.
    Anukam K; Osazuwa E; Ahonkhai I; Ngwu M; Osemene G; Bruce AW; Reid G
    Microbes Infect; 2006 May; 8(6):1450-4. PubMed ID: 16697231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicenter Trial of a Combination Probiotic for Children with Gastroenteritis.
    Freedman SB; Williamson-Urquhart S; Farion KJ; Gouin S; Willan AR; Poonai N; Hurley K; Sherman PM; Finkelstein Y; Lee BE; Pang XL; Chui L; Schnadower D; Xie J; Gorelick M; Schuh S;
    N Engl J Med; 2018 Nov; 379(21):2015-2026. PubMed ID: 30462939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy--a placebo-controlled, double-blind randomized pilot study.
    Myllyluoma E; Veijola L; Ahlroos T; Tynkkynen S; Kankuri E; Vapaatalo H; Rautelin H; Korpela R
    Aliment Pharmacol Ther; 2005 May; 21(10):1263-72. PubMed ID: 15882248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant probiotics improve the eradication effect of triple therapy for Helicobacter pylori infection.
    Du YQ; Su T; Fan JG; Lu YX; Zheng P; Li XH; Guo CY; Xu P; Gong YF; Li ZS
    World J Gastroenterol; 2012 Nov; 18(43):6302-7. PubMed ID: 23180952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study.
    Ringel-Kulka T; Palsson OS; Maier D; Carroll I; Galanko JA; Leyer G; Ringel Y
    J Clin Gastroenterol; 2011 Jul; 45(6):518-25. PubMed ID: 21436726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effectiveness of Probiotic
    Cukrowska B; Ceregra A; Maciorkowska E; Surowska B; Zegadło-Mylik MA; Konopka E; Trojanowska I; Zakrzewska M; Bierła JB; Zakrzewski M; Kanarek E; Motyl I
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33916192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.